Global Scopolamine Market Growth 2025-2031

The global Scopolamine market size is predicted to grow from US$ 11.7 million in 2025 to US$ 15.1 million in 2031; it is expected to grow at a CAGR of 4.4% from 2025 to 2031.

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.

LP Information, Inc. (LPI) ' newest research report, the “Scopolamine Industry Forecast” looks at past sales and reviews total world Scopolamine sales in 2024, providing a comprehensive analysis by region and market sector of projected Scopolamine sales for 2025 through 2031. With Scopolamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Scopolamine industry.

This Insight Report provides a comprehensive analysis of the global Scopolamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Scopolamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Scopolamine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Scopolamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Scopolamine.

This report presents a comprehensive overview, market shares, and growth opportunities of Scopolamine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others

Segmentation by Application:
Tablets
Injection
Patches

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin

Key Questions Addressed in this Report

What is the 10-year outlook for the global Scopolamine market?

What factors are driving Scopolamine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Scopolamine market opportunities vary by end market size?

How does Scopolamine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.